Just amazing-its PPS is lower than before approval! 

 

Ranexa is now available to at least 1 million more patients and its down and the drug isn't cheap? 

 

This market is more dysfunctional than the folks on that show "The Nanny"  hell you don't even want good news to come out in this market mess!

 

Between 20-25% shares short here.  Might be driving it down to cover?  This is what happens when you have great news but suspect visability, and it has implications for ACUS Al!?

 

I hold, but no sense buying-this might get dragged into the basement before it pretends to go where it should!

 

Kutz